A reverse transcriptase that lengthens a structure called the telomere. It consists of a protein component and an RNA component. The RNA component has been patented by Geron Corporation, U.S. Patent No. 5,583,016.
To the extent that shortening of the telomere is responsible for programmed cell death, telomerase can be said to convey cellular immortality.